CEP57 Antibody

What is CEP57 and why is it significant in cell biology research?

CEP57 (Centrosomal Protein 57kDa) is a critical pericentriolar material (PCM) component that functions as a microtubule-bundling protein in mammalian cells. Its significance lies in its role as a spindle pole- and microtubule-stabilizing factor essential for establishing robust spindle architecture during cell division. CEP57 interacts with NEDD1, which is necessary for its proper centrosome localization . Depletion studies have demonstrated that CEP57 absence leads to unaligned chromosomes and multipolar spindles, highlighting its importance in maintaining genomic stability . This makes CEP57 a valuable research target for understanding fundamental cellular processes and potential disease mechanisms.

Which experimental applications are most appropriate for different CEP57 antibody formats?

The selection of CEP57 antibody format should be guided by the specific experimental application:

• Western Blotting (WB): Both polyclonal and monoclonal antibodies work efficiently, with recommended dilutions typically between 1:500-1:2000 . Rabbit polyclonal antibodies targeting amino acids 1-240 or 19-128 show strong reactivity across human, mouse, and rat samples .

• Immunofluorescence (IF): For subcellular localization studies, rabbit polyclonal antibodies against amino acids 19-128 demonstrate excellent centrosomal staining. Mouse monoclonal antibodies (such as clone 1E9) also provide high specificity for human samples .

• Immunohistochemistry (IHC): For tissue section analysis, antibodies targeting the N-terminal region (AA 51-150) show optimal reactivity, particularly with paraffin-embedded and frozen sections .

• ELISA: Most CEP57 antibodies are suitable, with higher recommended dilutions (1:5000-1:10000) to minimize background .

How should researchers validate CEP57 antibody specificity before experimental use?

Proper validation is essential and should include multiple approaches:

• Positive controls: Include cells or tissues known to express CEP57, particularly centrosome-rich samples.

• Knockdown validation: Compare staining between wild-type cells and cells treated with CEP57-specific siRNAs (validated sequences include 5′-AAGCATGCAGAAATGGAGAGG-3′, 5′-AACCATCAAGGTCTAATGGAA-3′, and 5′-AACCAAATAACTAAAGTTCGA-3′) .

• Peptide competition: Pre-incubate the antibody with the immunogenic peptide to confirm binding specificity.

• Molecular weight confirmation: Verify the detected band corresponds to the expected size of CEP57 (~57kDa) in Western blotting.

• Subcellular localization: Confirm centrosomal staining pattern by co-localization with established centrosome markers like γ-tubulin .

What are the optimal immunoprecipitation protocols for studying CEP57 interactions with other centrosomal proteins?

For effective immunoprecipitation of CEP57 and its binding partners:

• Cell lysis conditions: Use a buffer containing 50 mM HEPES pH 7.4, 1 mM EDTA, 150 mM NaCl, 0.5% Triton X-100, supplemented with protease inhibitors (2 mM PMSF, 10 μg/ml Aprotinin, 5 μg/ml Pepstatin A) .

• Antibody selection: Rabbit polyclonal antibodies against full-length CEP57 have demonstrated superior precipitation efficiency for the protein complex .

• Incubation parameters: Incubate lysates with the CEP57 antibody overnight at 4°C, followed by 2-hour incubation with protein A-Sepharose beads .

• Washing steps: Perform five washes with lysis buffer to minimize non-specific binding while preserving genuine protein interactions .

• Detection strategy: When investigating interactions with γ-TuRC components (γ-tubulin, GCP2, NEDD1), include these proteins in your immunoblotting panel, as they have demonstrated interactions with CEP57 in previous studies .

How can researchers effectively use CEP57 antibodies for immunofluorescence microscopy to study centrosome dynamics?

For optimal immunofluorescence results:

• Fixation method: Use 2% paraformaldehyde with 0.1% glutaraldehyde for preserving centrosomal structures .

• Permeabilization: A brief (5-minute) extraction in PEM buffer containing 10 μM taxol and 0.1% Triton X-100 before fixation enhances centrosome visualization .

• Antibody combinations: For co-localization studies, pair CEP57 antibodies with NEDD1 antibodies, as these proteins show extensive co-localization and physical interaction at the centrosome .

• Signal amplification: For detecting low-abundance centrosomal CEP57, consider using fluorophore-conjugated secondary antibodies with high quantum yield (Alexa Fluor 488 or 568) .

• Image acquisition: Confocal microscopy with z-stack acquisition is recommended to capture the three-dimensional organization of centrosomal structures .

What methods can be employed to quantitatively assess CEP57 function using antibody-based approaches?

Several quantitative approaches can be implemented:

• FRET analysis: Use acceptor photobleaching assays with CEP57 (Alexa Fluor 488) and potential interaction partners like NEDD1 (Alexa Fluor 568) to quantify protein-protein interactions at the centrosome .

• Spindle length measurement: Following CEP57 depletion and immunostaining, measure spindle pole-to-pole distance using software like ImageJ to quantify the impact on spindle architecture .

• Microtubule density analysis: Quantify fluorescence intensity of microtubule staining in control versus CEP57-depleted cells to assess the protein's role in microtubule organization .

• Time-lapse microscopy: In cells expressing fluorescently-tagged α-tubulin, monitor spindle dynamics in real-time following CEP57 manipulation using systems like the PerkinElmer UltraVIEW VoX .

• Statistical validation: Apply appropriate statistical methods (Student's t-test for comparing two conditions) using software like SPSS to establish significance of observed differences .

How can researchers employ CEP57 antibodies in immuno-electron microscopy to resolve ultrastructural details?

For high-resolution localization of CEP57:

• Pre-embedding immunogold technique: Grow cells on coverslips, extract briefly in PEM buffer with 10 μM taxol and 0.1% Triton X-100, then fix with 2% PFA and 0.1% GA in PBS .

• Antibody incubation: Use mouse anti-CEP57 antibody followed by Nanogold-conjugated anti-mouse IgG antibody, incubating overnight at 4°C .

• Sample processing: Process cells according to standard EM preparation protocols, with dehydration and embedding in Epon resin .

• Imaging parameters: Employ transmission electron microscopy (such as JEOL JEM 1010) for visualization of gold particles indicating CEP57 localization relative to centrosomal ultrastructure .

• Comparative analysis: Compare ultrastructure between control cells and CEP57-depleted cells to understand the protein's contribution to centrosome and spindle architecture .

What approaches can resolve conflicting data from different CEP57 antibodies targeting distinct epitopes?

When faced with discrepancies between antibodies:

• Epitope mapping: Compare the amino acid sequences targeted by each antibody (e.g., AA 1-240 vs. AA 19-128 vs. AA 51-150) to understand potential differences in accessibility or conformation .

• Cross-validation: Employ multiple antibodies targeting different regions in parallel experiments to identify consensus findings and potential epitope-specific artifacts.

• Functional validation: Correlate antibody staining patterns with functional phenotypes after CEP57 depletion using siRNA approaches to determine which antibody most accurately reflects the protein's biological activity .

• Recombinant protein controls: Test antibodies against purified recombinant CEP57 fragments spanning different domains to assess binding specificity and affinity.

• Species-specific considerations: When working across species, consider that antibody reactivity may vary between human, mouse, and rat samples despite sequence conservation .

How can researchers integrate CEP57 antibody-based assays with live-cell imaging approaches?

To combine fixed-cell antibody staining with dynamic observations:

• Correlative microscopy: Perform live imaging of cells expressing fluorescently-tagged centrosome markers, then fix and immunostain for CEP57 to correlate dynamic behaviors with protein localization.

• Sequential approach: Track spindle dynamics in cells expressing α-tubulin-GFP using systems like the PerkinElmer UltraVIEW VoX, then fix and immunostain to determine CEP57 distribution relative to observed phenotypes .

• Validation controls: Generate stable cell lines expressing both fluorescently-tagged CEP57 and endogenous protein to confirm antibody specificity in the live-cell context.

• Combining RNAi with imaging: Transfect cells with siRNA against CEP57 along with α-tubulin-pCAsalGFP to directly visualize the consequences of protein depletion on microtubule dynamics .

• Quantitative correlation: Develop algorithms to correlate quantitative measurements from live imaging (spindle dynamics, microtubule flux) with subsequent immunofluorescence intensity data.

How should researchers interpret centrosomal versus non-centrosomal CEP57 staining patterns?

When analyzing localization patterns:

• Centrosomal enrichment: Authentic CEP57 signal should show strong enrichment at the centrosome with co-localization with established markers like γ-tubulin and NEDD1 .

• Cell-cycle dependence: Consider that CEP57 distribution may vary throughout the cell cycle, with potential changes in pericentriolar material organization during mitotic progression.

• Non-centrosomal signals: Evaluate potential non-specific binding versus biologically relevant non-centrosomal pools by comparing multiple antibodies and validation with siRNA-mediated depletion .

• Spindle-associated signals: CEP57 functions in spindle microtubule stability, so microtubule-associated staining during mitosis may represent genuine localization rather than background .

• Quantitative approaches: Measure the ratio of centrosomal to cytoplasmic signal intensity to establish objective criteria for distinguishing specific from non-specific staining.

What control experiments are essential when studying CEP57-NEDD1 interactions using antibody-based approaches?

To establish specificity of interaction:

• Reciprocal co-immunoprecipitation: Perform IP with anti-NEDD1 antibody and blot for CEP57, and vice versa, to confirm bidirectional interaction .

• Domain mapping controls: Include GST pull-down assays using NEDD1-NTD (1-350) and NEDD1-CTD (341-end) to confirm the specific interacting regions observed in previous studies .

• Competition assays: Introduce excess recombinant NEDD1-NTD to compete with endogenous NEDD1 for CEP57 binding.

• FRET negative controls: Include protein pairs known not to interact (e.g., CEP57 and centrin-2) when performing FRET analyses to control for non-specific energy transfer .

• Functional validation: Assess whether NEDD1 depletion affects CEP57 centrosomal localization, and whether this phenocopies aspects of direct CEP57 depletion .

What are the critical considerations when designing experiments to study CEP57's role in microtubule organization using antibodies?

Key experimental design elements include:

• Temporal controls: Compare CEP57 localization and microtubule organization at different cell cycle stages, particularly focusing on the transition from interphase to mitosis.

• Microtubule stability assessment: Combine CEP57 immunostaining with cold-stability assays or nocodazole treatment to differentiate its role in stabilizing different microtubule populations.

• Quantitative parameters: Measure spindle length, microtubule density, and spindle pole focusing following CEP57 manipulation to comprehensively assess its function .

• Resolution considerations: Employ super-resolution microscopy techniques when possible to resolve the precise spatial relationship between CEP57 and microtubule minus-ends at the centrosome.

• Functional redundancy: Consider potential compensatory mechanisms by simultaneously assessing related centrosomal proteins when CEP57 is depleted.